Dois-je éviter trifluoropropyl cyclotrisiloxane pendant la grossesse ? | VeriMom
No EU harmonised CLP (Annex VI) or Annex II/III cosmetic restriction found; supplier safety data sheets list H361 (suspected of damaging fertility or the unborn child) as a notified/self-classification, but no harmonised H360/H361 CLH entry was located on ECHA. No peer‑reviewed reproductive/developmental studies on this specific CAS (2374‑14‑3) were found in PubMed. (ECHA substance page; supplier SDS; PubChem).
ECHA regulatory hazard statements
- •H361
- •H361F
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- trifluoropropyl cyclotrisiloxane est-il sûr pendant la grossesse ?
- No EU harmonised CLP (Annex VI) or Annex II/III cosmetic restriction found; supplier safety data sheets list H361 (suspected of damaging fertility or the unborn child) as a notified/self-classification, but no harmonised H360/H361 CLH entry was located on ECHA. No peer‑reviewed reproductive/developmental studies on this specific CAS (2374‑14‑3) were found in PubMed. (ECHA substance page; supplier SDS; PubChem).
- trifluoropropyl cyclotrisiloxane est-il sûr pendant l'allaitement ?
- Same weight of evidence as pregnancy: no harmonised CMR classification or authoritative cosmetic-safety opinion (SCCS/CIR) found; some suppliers/SDSs notify reproductive hazard H361 but this appears to be company/self‑classification rather than a harmonised EU CLH. No specific data on transfer to breastmilk for this substance in the literature. (ECHA; supplier SDS).
- trifluoropropyl cyclotrisiloxane est-il sûr pour la peau de bébé ?
- Hazard evidence mirrors adult (no harmonised CLH; supplier self‑notifications of H361 only). Dermal exposure potential is low-to-measurable for cyclic siloxanes used topically, so exposure for infants is increased because of immature barrier and higher surface‑area‑to‑weight; per your scoring rules adult exposure scored as low (1) and infant exposure increased by +1. No infant-specific toxicokinetic or dermal absorption studies for CAS 2374‑14‑3 were found. (PubChem; supplier SDS; ECHA dossier).
- Comment VeriMom évalue-t-il trifluoropropyl cyclotrisiloxane ?
- VeriMom évalue trifluoropropyl cyclotrisiloxane à 33/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à trifluoropropyl cyclotrisiloxane pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à trifluoropropyl cyclotrisiloxane basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.